The Type II Transforming Growth Factor (TGF)-β Receptor-interacting Protein TRIP-1 Acts as a Modulator of the TGF-β Response
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The transforming growth factor-beta (TGF-beta) receptor interacting protein TRIP-1 was originally identified as a WD40 repeat-containing protein that has the ability to associate with the TGF-beta type II receptor and is phosphorylated by it (1). However, its function was not known. We now show that TRIP-1 expression represses the ability of TGF-beta to induce transcription from the plasminogen activator inhibitor-1 promoter, a common reporter of the TGF-beta-induced gene expression response, but does not affect the ability of TGF-beta to inhibit cyclin A transcription. TRIP-1 can also inhibit the plasminogen activator inhibitor-1 expression induced by Smads as well as activated TGF-beta type I receptors. Its inhibitory effect is exerted by a combination of receptor-dependent and receptor-independent mechanisms. Deletion mutational analysis revealed that two distinct regions, which do not contain recognizable WD40 repeats, are required for the ability of TRIP-1 to inhibit the gene expression response. Expression of other segments of TRIP-1 increased the TGF-beta-induced gene expression response and therefore may exert a dominant negative phenotype. We conclude that TRIP-1 acts as a modulator of the TGF-beta response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
Cited by
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Self-citationTGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Self-citationTRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
Massagué, J., & Chen, Y.-G. (2000) · Genes & Development · doi:10.1101/gad.14.6.627 · Cited by 1,575
TGF-β Signaling from Receptors to Smads
Hata, A., & Chen, Y.-G. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022061 · Cited by 888
Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily
Chang, H., Brown, C. W., & Matzuk, M. M. (2002) · Endocrine Reviews · doi:10.1210/er.2002-0003 · Cited by 787
TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses
Yu, L. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf366 · Cited by 721
Specificity, diversity, and regulation in TGF‐β superfamily signaling
PIEK, E., HELDIN, C., & DIJKE, P. T. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2105 · Cited by 656
Role of Transforming Growth Factor-beta Signaling in Cancer
de Caestecker, M. P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.17.1388 · Cited by 522
Proteomic and immunologic analyses of brain tumor exosomes
Graner, M. W., Alzate, O., Dechkovskaia, A. M., Keene, J. D., Sampson, J. H., Mitchell, D. A., & Bigner, D. D. (2009) · The FASEB Journal · doi:10.1096/fj.08-122184 · Cited by 429
Bone physiology as inspiration for tissue regenerative therapies
Lopes, D., Martins-Cruz, C., Oliveira, M. B., & Mano, J. F. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.028 · Cited by 421
‘Yin–Yang’ functions of transforming growth factor‐β and T regulatory cells in immune regulation
Wan, Y. Y., & Flavell, R. A. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00565.x · Cited by 380
Phospho-control of TGF-β superfamily signaling
Wrighton, K. H., Lin, X., & Feng, X.-H. (2009) · Cell Research · doi:10.1038/cr.2008.327 · Cited by 363
TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation
Perlman, R., Schiemann, W. P., Brooks, M. W., Lodish, H. F., & Weinberg, R. A. (2001) · Nature Cell Biology · doi:10.1038/35087019 · Cited by 349
Welt, C., Sidis, Y., Keutmann, H., & Schneyer, A. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700905 · Cited by 324
TGF-β signal transduction and mesangial cell fibrogenesis
Schnaper, H. W., Hayashida, T., Hubchak, S. C., & Poncelet, A.-C. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00300.2002 · Cited by 311
Factors Involved in the Regulation of Type I Collagen Gene Expression: Implication in Fibrosis
Ghosh, A. K. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700502 · Cited by 259
TGF-β and Regulatory T Cell in Immunity and Autoimmunity
Wan, Y. Y., & Flavell, R. A. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9251-y · Cited by 186
STRAP and Smad7 Synergize in the Inhibition of Transforming Growth Factor β Signaling
Datta, P. K., & Moses, H. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3157-3167.2000 · Cited by 175
“STRAP(1-294) showed the same inhibitory effect as wild-type STRAP, either in the absence or presence of Smad7 (Fig.”
BackgroundMethodResultInfluentialScarless wound healing: From development to senescence
Pratsinis, H., Mavrogonatou, E., & Kletsas, D. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.011 · Cited by 103
Brassinosteroids Plant counterparts to animal steroid hormones?
Clouse, S. D. (2002) · Vitamins & Hormones · doi:10.1016/s0083-6729(02)65065-4 · Cited by 40
Metadata
- Authors
- Choy, L., & Derynck, R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-11
- Volume
- 273
- Issue
- 47
- Pages
- 31455-31462
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2129003871
- Cited by
- 125
- References
- 1
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.